Jeil Pharma Holdings Inc (002620.KS) KSC

8,220.00

-90(-1.08%)

Updated at October 20 09:45AM

Currency In KRW

Valuation

Market Cap120.04B
Enterprise Value215.44B
P/E Ratio-3.63
PEG Ratio-0.13
Price/Sales Ratio0.17
Price/Book Ratio0.41
Enterprise/Revenue0.33
Enterprise/EBITDA5.97

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.05
Operating Margin0.02

Management Effectiveness

Return On Assets-0.04
Return On Equity-0.11

Income Statement

Revenue779.82B
Revenue/Share47,877.84
Gross Profit206.52B
EBITDA-38.65B
Net Income-51.16B
Diluted EPS-3,323.31

Balance Sheet

Total Cash71.18B
Total Cash/Share4,631.41
Total Debt169.98B
Total Debt/Equity0.55
Current Ratio1.14
Book Value Per Share29,000.44

Price History

52-Week Change-6.73
52-Week High9,920
52-Week Low6,950
Moving Average 50 Days8,738.8
Moving Average 200 Days8,223.3

Statistics

Average Volume19,011
Shares Outstanding15.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate50
Trailing Annual Dividend Yield0.6
Payout Ratio-0.01
Last Split Factor292627:1000000
Last Split DateJuly 17, 2017